Outbreak of vim-1-carbapenemase-producing enterobacter cloacae in a pediatric intensive care unit

Pediatric Infectious Disease Journal

Volumn 29, Issue 12, 2010, Pages 1144-1146

  Oteo, Jesús ^a   Hernández Almaraz, José Luis ^b   Gil Antón, Javier ^b   Vindel, Ana ^a   Fernández, Sara ^a   Bautista, Verónica ^a   Campos, José ^a,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c CSIC   (Spain)

Author keywords

enterobacteria; metallo lactamases; outbreak; VIM 1

Indexed keywords

AMIKACIN; CARBAPENEMASE; CARBAPENEMASE VIM 1; CEFTAZIDIME; COTRIMOXAZOLE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CASE REPORT; CHILD; CONGENITAL HEART DISEASE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; EPIDEMIC; FECES MICROFLORA; FEMALE; GASTROTOMY; HUMAN; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MALE; NONHUMAN; PAKISTAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD; SPAIN;

AMIKACIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; INTEGRONS; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PLASMIDS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 78649489391     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181efaa2d     Document Type: Article

References (11)

1. Overtuf GD. Carbapenemases: a brief review for pedriatic infectious diseases specialists. Pediatr Infect Dis J. 2010;29:68-70.
2. Walsh TR, Toleman MA, Poirel L, et al. Metallo-b-lactamases: the quiet before the storm? Clin Microbiol Rev. 2005;18:306-325.
3. Miro E, Segura C, Navarro F, et al. Spread of plasmids containing the bla(VIM-1) and CTX-M genes and the qnr determinant in Enterobacter cloacae, Klebsiella pneumoniae and Klebsiella oxytoca isolates. J Antimi-crob Chemother. 2010;65:661-665.
4. Falcone M, Mezzatesta ML, Perilli M, et al. Infections with VIM-1 metallo-/3-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol. 2009;47:3514-3519.
5. Tato M, Coque TM, Baquero F, et al. Dispersal of carbapenemasa blaVIM-1 gene associated with different Tn402 variants, mercury trans-posons, and conjugative plasmids in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010;54:320-327.
6. Souli M, Kontopidou FV, Papadomichelakis E, et al. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. Clin Infect Dis. 2008;46: 847-854.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 20th Informational Supplement. M100-S20, vol. 30, no. 1. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
8. Oteo J, Delgado-Iribarren A, Vega D, et al. Emergence of imipenem resistance in clinical Escherichia coli during therapy. Int J Antimicrob Agents. 2008;32:534-537.
9. Carattoli A, Bertini A, Villa L, et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219-228.
10. Cardoso O, Alves AF, Leitao R. Metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from a cystic fibrosis patient. Int J Antimicrob Agents. 2008;31:375-379.
11. Cendejas E, Gomez-Gil R, Gomez-Sanchez P, et al. Detection and characterization of Enterobacteriaceae producing metallo-beta-lactama-ses in a tertiary-care hospital in Spain. Clin Microbiol Infect. 2010;16: 181-183.